PTSD Trial, Recruiting (NCT06288711)

PTSD Trial, Recruiting NCT06288711 Sponsor: University of Vermont Condition: PTSD

Printed from Voxsanity (voxsanity.com.au) — NCT06288711 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ptsd

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are over 18 years old
People who have been on a stable dose of methadone or buprenorphine for more than one month before the study begins
People who have been diagnosed with post-traumatic stress disorder (PTSD) according to a structured clinical assessment
People who take psychiatric medications and have been on a stable dose of those medications for more than one month before enrolling

Who may not be able to join:

People who are currently experiencing delusions or hallucinations, have unstable bipolar disorder, or are assessed as being at immediate risk of suicide
People who show signs of significant cognitive impairment based on a standardised memory and thinking assessment
People who are already enrolled in another recognised treatment program specifically for PTSD
People who are pregnant, as confirmed by a pregnancy test
People who do not have access to mobile phone service

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8026569610

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06288711

Sponsor: University of Vermont

Phase: Not Applicable

Status: Recruiting

Condition: PTSD

Trial contact: 8026569610

More information: https://clinicaltrials.gov/study/NCT06288711

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are over 18 years old
People who have been on a stable dose of methadone or buprenorphine for more than one month before the study begins
People who have been diagnosed with post-traumatic stress disorder (PTSD) according to a structured clinical assessment
People who take psychiatric medications and have been on a stable dose of those medications for more than one month before enrolling

Who may not be able to join:

People who are currently experiencing delusions or hallucinations, have unstable bipolar disorder, or are assessed as being at immediate risk of suicide
People who show signs of significant cognitive impairment based on a standardised memory and thinking assessment
People who are already enrolled in another recognised treatment program specifically for PTSD
People who are pregnant, as confirmed by a pregnancy test
People who do not have access to mobile phone service

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of Vermont

Registry

ClinicalTrials.gov

Start date

3 June 2024

Est. completion

31 August 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Prolonged exposure therapy session attendance; Prolonged exposure therapy completion; Change in posttraumatic stress disorder symptom severity - clinician rated

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov